Condition: Sickle Cell Disease · Sickle Beta Zero Thalassemia · Sickle B+ Thalassemia · Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.
This description comes directly from the study's public registry record.
Sherif M Badawy, MD, MS · (312) 227-4836 · sbadawy@luriechildrens.org
Savannah Winkler, BS · (312) 227-4807 · swinkler@luriechildrens.org
Always discuss trial participation with your own doctor first.
| Ann & Robert H Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04688411